Water technology company Xylem (NYSE: XYL) announced better-than-expected revenue in Q1 CY2026, with sales up 2.7% year on year to $2.13 billion. The company’s full-year revenue guidance of $9.25 billion at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $1.12 per share was 3.3% above analysts’ consensus estimates.

Is now the time to buy XYL? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Xylem’s first quarter results were met with a negative market reaction, as organic revenue was flat and fell short of analysts’ expectations despite total reported revenue growth. Management attributed performance to resilient demand in the U.S. municipal and utility markets, particularly in Water Infrastructure and Measurement and Control Solutions. CEO Matthew Pine acknowledged the impact of project timing, ongoing softness in China, and portfolio simplification efforts, noting, “Orders were flat versus last year, driven by project timing in WSS offsetting strength in the other segments.”

Looking ahead, management’s guidance for the year is anchored by expectations of margin expansion from productivity initiatives, a normalization of project mix, and continued pricing discipline to offset inflation. CFO Bill Grogan emphasized that benefits from ongoing simplification efforts and a healthy order backlog should support improved results, while cautioning that macro uncertainty and geopolitical risks could impact execution. Pine highlighted, “Our balanced outlook reflects our strong commercial position, the durability of our portfolio, and benefits from our simplification efforts.”

Key Insights from Management’s Remarks

Management cited strong U.S. utility demand, a record outsourced contract win, and progress on portfolio transformation as key factors shaping the quarter.

• U.S. utility resilience: Management reported robust demand from U.S. utilities, with CEO Matthew Pine stating utility orders in the U.S. rose double digits, supported by aging infrastructure and no signs of funding pullbacks among major customers.
• Largest contract in company history: Xylem secured an $850 million, 20-year outsourced water contract in its Water Solutions and Services (WSS) segment, representing 75% service and 25% capital components, seen as a milestone validating the company’s strategic focus on recurring service revenue.
• China and Western Europe softness: Revenue and orders in China were down 30% year-over-year, which management attributed to a combination of market headwinds, competitor actions, and deliberate walk-aways from lower-margin business. Western Europe was also impacted by portfolio simplification initiatives.
• Measurement and Control Solutions (MCS) orders growth: MCS segment orders increased 15%, driven by strong demand for smart metering in the U.S. and a rebound in delayed projects, although segment margins were pressured by unfavorable mix and inflation.
• Active portfolio management and M&A: The company advanced its M&A strategy with the announced acquisition of a German water quality instruments business for $219 million, strengthening its analytics offerings. The pending MCS metering divestiture was delayed due to regulatory approvals, impacting short-term outlook.

Drivers of Future Performance

Management expects future performance to be shaped by margin expansion from improved mix, continued pricing discipline, and execution on backlog as project timing and portfolio changes normalize.

• Seasonal and mix-driven growth: CFO Bill Grogan projected a significant volume ramp in the second half of the year, driven by seasonal factors and normalization of project mix, particularly in MCS and Water Infrastructure.
• Margin improvement initiatives: Management expects margin expansion to come from productivity gains, structural cost reductions, and price realization, offsetting inflation and mix pressure, with Applied Water and MCS segments targeted for improved profitability as the year progresses.
• Macro and geopolitical risks: The company remains cautious about external risks, including geopolitical instability, potential tariff changes, and raw material inflation, noting that their nimble supply chain and pricing strategies are designed to manage cost volatility but may face challenges if conditions worsen.

Catalysts in Upcoming Quarters

Our team will be watching (1) the pace of backlog conversion into revenue, particularly in MCS and Water Infrastructure as delayed projects are executed; (2) the margin recovery in Applied Water and the impact of cost actions; and (3) the successful integration of the new analytics acquisition and progress on the metering divestiture. Monitoring macro trends in China and ongoing service contract wins will also be key to tracking Xylem’s execution.

Xylem currently trades at $119.96, down from $123.51 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).

High Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.